|
 |
European BioPharmaceutical Review
|
| Sue Charles describes how scientific corporate communications is vital in securing public confidence, and the role it can play in increasing a company’s value
With new technologies constantly emerging from academic and commercial environments, communicating the potential applications of exciting scientific and technological developments is crucial in order to gain public understanding and investor confidence. The peer community, the general public and potential investors all need to be clear on the benefits and possibilities generated by such discoveries. However, communicating the key messages and intricacies of these developments can be complex in certain areas, where there are potential pitfalls to be avoided. WHY SHOULD COMPANIES INVEST IN COMMUNICATIONS?
The benefits of communications to a company can be vast, ranging from increased internal confidence and satisfaction from employees to raising the share price of a publicly listed company. However, for many companies starting out, expense can be an issue, so any potential investment in communications should be assessed in order that the potential benefits in returns outweigh the investment. For new companies where cashflow can be tight, a judgment is needed regarding how the returns will outweigh the investment.
Communications needs vary from company to company, but there remain some common benefits from investing in this area:
- Business and scientific partners become aware of the company’s products and capabilities and develop confidence in them
- Investors develop an understanding of the business, enabling them to analyse and evaluate the company appropriately
- Media become familiar with the company, thereby increasing chance of coverage
- Accurate coverage and clearer portrayal of the story is possible when the ‘picture of the puzzle’ and the ‘pieces of the puzzle’ are effectively communicated to the media
- Effective issue management protects against diminishing company value
- Builds morale internally amongst employees and other stakeholders
WHAT TYPES OF COMMUNICATIONS ARE AVAILABLE?
There are vast numbers of ways in which to communicate. Depending on the company’s stage of development, there may be some types of communication that are more appropriate than others. The communications methods used and the value gained will be specific to a company at a certain stage of its development. For example, a basic website with contact details and information may be appropriate when a company is just starting out, but will need significant development as it matures. A mature company’s website is likely to contain history, ‘about us’, management, technology, news and events and investor and contact information sections. A company’s range of marketing materials will also increase as the company grows, from initial basic factsheets to annual reports. Posters, exhibition stands and even videos may also be developed for large conferences, so the range of materials available to convey a message are potentially vast, although not always obvious from the outset. The media can, of course, also be a very important conduit in communications. |
Read full article >>
|
 |
 |
 |
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
5 |
| | | | | |
|
 |
Sue Charles, Managing Partner, Life Sciences at College Hill, is a recognised leader in the field of life science communications, having been in the sector since 1985. Sue was the CEO and co-founder of Northbank Communications, a full-service communications consultancy focused on science-based sectors, which was acquired by College Hill in October 2007. Prior to Northbank, Sue founded and led a number of communications companies, including the UK’s first biotech specialist financial PR agency. She also has experience as interim CEO of a biotech start-up as well as several non-executive directorships. She has received several awards for her enterprise and business achievements. Sue has a first-class degree in Biochemistry from Oxford University, PhD level research experience in Genetics and an MBA from Cranfield, one of Europe’s top business schools, as well as qualifications and training in marketing and investor relations. She is a member of the UK Chartered Institute of Public Relations, the UK Chartered Institute of Marketing and the UK Association of British Science Writers. She is renowned for her PR work around the launch of Dolly the sheep onto the global stage. |
|
 |
 |
 |
|

 |
Industry Events |
 |
Clinical Trials in CNS
25-26 November 2008, Copthorne Tara Hotel, London, UK
SMi present their 7th annual conference… Clinical Trials in CNS 25th to 26th November 2008, Copthorne Tara Hotel, London, UK
More info >> |
|
 |
News and Press Releases |
 |
Lilly Selects ICON to Manage its Clinical Data Management Business Outside the US
18th November 2008
More info >> |
|
|